TL;DR
A narrative review summarizing the most important practice-changing studies involving immune checkpoint inhibitors in gynecological cancers, particularly in cervical, endometrial, ovarian and vulvar cancer are presented.
AI-generated by Semantic Scholar
Authors
Cecilia Nasso, Silvia Puglisi, Sara Elena Rebuzzi, Veronica Errigo, Francesca Rosa, Ilaria Chiola, Caterina Lazzari, Yuri Musizzano, Ezio Venturino, Alessandro Gastaldo, Caterina Siccardi, Eugenio Oreste Volpi, Serafina Mammoliti, Marco Benasso
